Results 31 to 40 of about 7,376 (242)
A 53-year-old man presented with an erythematous papular skin eruption. Ten days prior to the appearance of the lesions, he had received the second dose of the coronavirus disease 2019 (COVID19) vaccine (ChAdOx1 nCoV-19 [AstraZeneca]).
Jun Ki Hong +4 more
semanticscholar +1 more source
Intertriginous Xanthomas: Clues to Homozygous Familial Hypercholesterolemia [PDF]
Nikhil Mehta +3 more
doaj +2 more sources
Symmetrical drug‐related intertriginous and flexural exanthema‐like eruption after COVID‐19 vaccine
var-iant of BS referred as symmetrical drug-related intertriginous and flexural exanthema (SDRIFE). report two cases of SDRIFE-like eruption occurring after COVID-19 vaccine.
I. Lahouel +7 more
semanticscholar +1 more source
An intertriginous hyperpigmented macular eruption
A 23-year-old woman presented with a hyperpigmented intertriginous eruption unresponsive to topical steroids and to topical and systemic antifungals. Histopathological assessment demonstrated patchy inflammatory infiltrate at the demoepidermal junction ...
C. Harnett +3 more
semanticscholar +1 more source
The Journal of Clinical Pharmacology 2022, 62(10) 1325–1327 © 2022, The American College of Clinical Pharmacology. DOI: 10.1002/jcph.2069 Vancomycin Associated Purpuric Symmetrical Drug-Related Intertriginous and Flexural Exanthema:A Rare Association and
R. Kothari +6 more
semanticscholar +1 more source
Although soft fibromas occur in the intertriginous area, including on the neck, axillae, and vulvovaginal locations, in rare cases, they can develop in the nipple.
Toshiyuki Yamaguchi
doaj +1 more source
Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases [PDF]
Fluticasone propionate - the first carbothioate corticosteroid - has been classified as a potent anti-inflammatory drug for dermatological use. It is available as 0.05% cream and 0.005% ointment formulations for the acute and maintenance treatment of ...
Atsuta J +33 more
core +1 more source
Symmetric drug‐related intertriginous and flexural exanthema (SDRIFE) is a cutaneous drug reaction characterized by gluteal/anogenital erythema and symmetric involvement of other intertriginous location(s) without systemic signs.
A. Schuler +7 more
semanticscholar +1 more source
This is a case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption following ChAdOx1 nCoV‐19 (AstraZeneca‐Oxford) vaccination. Investigations, including repeated skin swabs, ruled out an infectious cause.
P. N. Lim, G. Wylie
semanticscholar +1 more source
Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema
is missing (Short communication)
Emily Y. Kim +2 more
doaj +1 more source

